JP Morgan Chase’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$133M Buy
1,862,805
+837,700
+82% +$45.2M 0.01% 928
2026
Q1
$53.3M Buy
1,025,105
+266,023
+35% +$16M ﹤0.01% 1362
2025
Q4
$44.6M Buy
759,082
+33,997
+5% +$2.07M ﹤0.01% 1440
2025
Q3
$40.3M Sell
725,085
-633,738
-47% -$33.9M ﹤0.01% 1547
2025
Q2
$69.9M Buy
1,358,823
+470,339
+53% +$23.6M ﹤0.01% 1134
2025
Q1
$52.1M Buy
888,484
+363,384
+69% +$24.6M ﹤0.01% 1293
2024
Q4
$37.8M Sell
525,100
-231,084
-31% -$17M ﹤0.01% 1501
2024
Q3
$60.4M Sell
756,184
-150,782
-17% -$11.3M ﹤0.01% 1208
2024
Q2
$65M Buy
906,966
+185,206
+26% +$13.6M 0.01% 1120
2024
Q1
$50.8M Buy
721,760
+158,899
+28% +$11.4M ﹤0.01% 1272
2023
Q4
$43.4M Sell
562,861
-38,346
-6% -$2.53M ﹤0.01% 1296
2023
Q3
$40.9M Sell
601,207
-46,495
-7% -$3.67M ﹤0.01% 1210
2023
Q2
$52.9M Buy
647,702
+86,717
+15% +$6.97M 0.01% 1098
2023
Q1
$41.6M Buy
560,985
+40,902
+8% +$3.15M 0.01% 1192
2022
Q4
$43.1M Sell
520,083
-58,585
-10% -$4.65M 0.01% 1191
2022
Q3
$41.1M Sell
578,668
-26,644
-4% -$2.3M 0.01% 1143
2022
Q2
$52.5M Sell
605,312
-4,884
-0.8% -$458K 0.01% 1012
2022
Q1
$66.1M Sell
610,196
-34,168
-5% -$3.53M 0.01% 1026
2021
Q4
$83.3M Sell
644,364
-224,372
-26% -$27.5M 0.01% 962
2021
Q3
$105M Sell
868,736
-552
-0.1% -$67.2K 0.01% 838
2021
Q2
$97.9M Buy
869,288
+33,296
+4% +$3.5M 0.01% 910
2021
Q1
$79.8M Buy
835,992
+206,084
+33% +$18.8M 0.01% 949
2020
Q4
$50M Buy
629,908
+178,800
+40% +$12.9M 0.01% 1073
2020
Q3
$27.8M Buy
451,108
+60,576
+16% +$3.94M ﹤0.01% 1284
2020
Q2
$25.8M Buy
390,532
+96,684
+33% +$5.79M 0.01% 1224
2020
Q1
$13.9M Buy
293,848
+22,248
+8% +$1.11M ﹤0.01% 1484
2019
Q4
$14.9M Sell
271,600
-10,856
-4% -$570K ﹤0.01% 1801
2019
Q3
$13.8M Buy
282,456
+114,312
+68% +$5.73M ﹤0.01% 1873
2019
Q2
$8.68M Sell
168,144
-11,312
-6% -$570K ﹤0.01% 2212
2019
Q1
$8.91M Buy
179,456
+7,284
+4% +$328K ﹤0.01% 2156
2018
Q4
$6.23M Sell
172,172
-135,252
-44% -$5.65M ﹤0.01% 2399
2018
Q3
$15.7M Buy
307,424
+33,920
+12% +$1.5M ﹤0.01% 1849
2018
Q2
$10.1M Sell
273,504
-676
-0.2% -$25.8K ﹤0.01% 2138
2018
Q1
$10.4M Buy
274,180
+101,804
+59% +$3.6M ﹤0.01% 2005
2017
Q4
$5.58M Buy
172,376
+167,468
+3,412% +$5.32M ﹤0.01% 2600
2017
Q3
$148K Sell
4,908
-19,228
-80% -$571K ﹤0.01% 4199
2017
Q2
$709K Buy
24,136
+20,984
+666% +$574K ﹤0.01% 3587
2017
Q1
$80K Sell
3,152
-23,324
-88% -$602K ﹤0.01% 4401
2016
Q4
$681K Buy
26,476
+18,948
+252% +$498K ﹤0.01% 3610
2016
Q3
$207K Sell
7,528
-7,532
-50% -$207K ﹤0.01% 3674
2016
Q2
$424K Buy
15,060
+2,404
+19% +$61.8K ﹤0.01% 3492
2016
Q1
$300K Buy
12,656
+5,568
+79% +$123K ﹤0.01% 3510
2015
Q4
$160K Sell
7,088
-4,904
-41% -$112K ﹤0.01% 3705
2015
Q3
$277K Buy
+11,992
New +$301K ﹤0.01% 3602
2015
Q2
Sell
-67,224
Closed -$1.69M 4171
2015
Q1
$1.69M Sell
67,224
-129,172
-66% -$3.07M ﹤0.01% 2957
2014
Q4
$4.54M Buy
196,396
+157,308
+402% +$3.6M ﹤0.01% 2470
2014
Q3
$914K Sell
39,088
-65,472
-63% -$1.53M ﹤0.01% 3390
2014
Q2
$2.42M Buy
104,560
+37,728
+56% +$834K ﹤0.01% 2424
2014
Q1
$1.43M Sell
66,832
-38,344
-36% -$863K ﹤0.01% 2708
2013
Q4
$2.49M Buy
105,176
+17,200
+20% +$373K ﹤0.01% 2623
2013
Q3
$1.76M Buy
87,976
+4,112
+5% +$78K ﹤0.01% 2892
2013
Q2
$1.45M Buy
+83,864
New +$1.39M ﹤0.01% 3025

Other funds holding TECH

JP Morgan Chase's TECH Position: Q2 2026 in Review

JP Morgan Chase increased its Bio-Techne (TECH) stake by 82% in Q2 2026, buying an estimated $45.2M and bringing the position to 1,862,805 shares worth $133M. The position accounts for 0.01% of the portfolio, ranked #928.

JP Morgan Chase first reported a position in TECH in Q2 2013 and has held it in 52 quarters since. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • JP Morgan Chase held 1,862,805 shares of Bio-Techne worth $133M as of Q2 2026.
  • JP Morgan Chase bought 837,700 Bio-Techne shares in Q2 2026, an estimated $45.2M.
  • Bio-Techne made up 0.01% of JP Morgan Chase's portfolio in Q2 2026, its #928 holding.
  • JP Morgan Chase first reported a position in Bio-Techne in Q2 2013 and has held it in 52 quarters since.
  • 593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.